Nelson Chao
Präsident bei American Society for Blood & Marrow Transplantation
Profil
Nelson Chao is the founder of Aldagen, Inc., which was founded in 2000.
He held the title of Secretary from 2009 to 2012.
Currently, he holds the title of Principal at Duke University Medical Center and the title of President at American Society for Blood & Marrow Transplantation.
Aktive Positionen von Nelson Chao
| Unternehmen | Position | Beginn |
|---|---|---|
| Duke University Medical Center | Corporate Officer/Principal | - |
| American Society for Blood & Marrow Transplantation | Präsident | - |
Ehemalige bekannte Positionen von Nelson Chao
| Unternehmen | Position | Ende |
|---|---|---|
Aldagen, Inc.
 Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Health Technology |
| American Society for Blood & Marrow Transplantation |